Find Clinical Trial

Assessment of Active Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa) plasma kinetics in Patients at acute stage of Ischemic Stroke: Prospective, Multicentre, Open, Non-randomised, Biomarker Study – TAFIa levels in Acute Stroke


← Back
Study Phase

Phase 2

Therapeutic Area

Cardiovascular Diseases

IndicationStroke
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device

RTCCAR

Active Substance CodeRTCCAR
Protocol CodeCL2-RTCCAR-001
EudraCT Code2017-002760-41


Documents and links

Results summary READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2022 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility